TNFRSF10A and colonic neoplasm: Here, we utilized the artemisinin derivatives in combination with the DR4-specific TRAIL variant 4C7 [26] and the DR5-specific TRAIL variant DHER [27] to stimulate TRAIL-induced apoptosis in colon cancer cells.